Animal Health Global Innovation
Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our internal colleagues in human health and with many external partners to deliver breakthrough animal health therapies, and we maximize our ability to enhance the wellbeing of animals by focusing on areas that will impact the greatest number of animals. Our broad portfolio of veterinary therapeutics, parasiticides and vaccines reflects Boehringer Ingelheim’s strong commitment to delivering value through innovation.
A key area of expertise within Global Innovation is the discovery and development of new parasiticides for both companion animals and livestock. Parasiticides – such as our Heartgard®, Frontline®, NexGard®, Ivomec® and LongRange® lines – have transformed the health of animals across the globe in the past several decades.
As a leader in parasiticides, we are committed to continuing the development of science-based innovations for prevention of parasitic diseases that address key unmet needs, including resistance, convenience and sustainability. Through our dedicated discovery and screening efforts to identify new active molecules; investment in innovative approaches including monoclonal antibodies, peptides and vaccines; and in-house and external development expertise; we will continue to deliver truly transformative products to improve animal well-being.